the ion implant technology technology ( mtm ) is a highly implant intensive segment that is expected to account for approximately 80% of our system revenue in 2022. we are executing at a very high level despite a challenging environment. we are executing at a very high level despite a challenging environment. we are executing at a very high level despite a challenging environment. we expect that axcelis will emerge from this period with a stronger and much more resilient business.